199 related articles for article (PubMed ID: 9681523)
1. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.
Wu X; Gu J; Patt Y; Hassan M; Spitz MR; Beasley RP; Hwang LY
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):567-70. PubMed ID: 9681523
[TBL] [Abstract][Full Text] [Related]
2. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
[TBL] [Abstract][Full Text] [Related]
3. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
Wang LE; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
Clin Cancer Res; 1998 Jul; 4(7):1773-8. PubMed ID: 9676854
[TBL] [Abstract][Full Text] [Related]
4. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls.
Wu X; Gu J; Amos CI; Jiang H; Hong WK; Spitz MR
Cancer; 1998 Sep; 83(6):1118-27. PubMed ID: 9740076
[TBL] [Abstract][Full Text] [Related]
5. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study.
Xiong P; Bondy ML; Li D; Shen H; Wang LE; Singletary SE; Spitz MR; Wei Q
Cancer Res; 2001 Dec; 61(23):8465-9. PubMed ID: 11731429
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
[TBL] [Abstract][Full Text] [Related]
9. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
[TBL] [Abstract][Full Text] [Related]
10. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
[TBL] [Abstract][Full Text] [Related]
11. BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk.
Zhu Y; Spitz MR; Zheng YL; Hong WK; Wu X
Cancer; 2002 Aug; 95(3):563-8. PubMed ID: 12209748
[TBL] [Abstract][Full Text] [Related]
12. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
[TBL] [Abstract][Full Text] [Related]
13. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines.
Wei Q; Spitz MR; Gu J; Cheng L; Xu X; Strom SS; Kripke ML; Hsu TC
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):199-204. PubMed ID: 8833620
[TBL] [Abstract][Full Text] [Related]
14. Mutagen sensitivity of patients with cancer at different sites of the head and neck.
Székely G; Remenár E; Kásler M; Gundy S
Mutagenesis; 2005 Sep; 20(5):381-5. PubMed ID: 16105906
[TBL] [Abstract][Full Text] [Related]
15. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
[TBL] [Abstract][Full Text] [Related]
16. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation.
Lin J; Swan GE; Shields PG; Benowitz NL; Gu J; Amos CI; de Andrade M; Spitz MR; Wu X
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2065-71. PubMed ID: 17932354
[TBL] [Abstract][Full Text] [Related]
17. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer.
Motykiewicz G; Faraglia B; Wang LW; Terry MB; Senie RT; Santella RM
Environ Mol Mutagen; 2002; 40(2):93-100. PubMed ID: 12203401
[TBL] [Abstract][Full Text] [Related]
18. [Determination of genetic susceptibility for development of squamous epithelial carcinomas of the had and neck with bleomycin-induced chromosome instability].
Cloos J; Snow GB; Braakhuis BJ
Laryngorhinootologie; 1995 Dec; 74(12):742-7. PubMed ID: 8579674
[TBL] [Abstract][Full Text] [Related]
19. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis.
Spitz MR; Fueger JJ; Halabi S; Schantz SP; Sample D; Hsu TC
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):329-33. PubMed ID: 7688625
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cell cycle control in bleomycin-induced mutagen sensitivity.
Cloos J; Temmink O; Ceelen M; Snel MH; Leemans CR; Braakhuis BJ
Environ Mol Mutagen; 2002; 40(2):79-84. PubMed ID: 12203399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]